AQP2 and congestive heart failure: Compared with the CHF group, the AQP2 protein abundance was reduced in both the QL group and the Valsartan group (P < 0.05), while no significant differences were observed in AQP2 protein abundance between QL group and Valsartan group (P > 0.05).